Indefinite Delivery Contract 75D30119D05105
Award Date
7/1/19
Last Date to Order
6/30/20
Federal Agency
CDC Pittsburgh
Awardee
Merck Sharp & Dohme LLC
Ultimate Awardee
Schering Plough Corporation
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Centers for Disease Control and Prevention (CDC) has awarded a multiple-award Indefinite Delivery Contract (IDC) valued up to $69,520,654.32 to Merck Sharp & Dohme LLC, doing business as Merck, for the supply of various adult vaccines. The contract has a period of performance from July 1, 2024 to June 30, 2025 and does not involve any set-aside designations. The IDC requires Merck, as a pharmaceutical manufacturer, to provide a wide range of adult vaccines including Hepatitis A,...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Merck Sharp & Dohme LLC, doing business as Merck, for the purchase of 20 standard pediatric vaccines. The contract supports the CDC's Vaccines for Children program and adult vaccination initiatives under Section 317(j) of the Public Health Service Act. This multiple award IDC has a total ceiling value of $2,565,312,500 and a period of performance of 12 months from the award date...
This indefinite delivery contract was awarded to Merck Sharp & Dohme LLC, doing business as Merck, by the Centers for Disease Control and Prevention (CDC) Pittsburgh to procure a variety of pharmaceutical drugs and vaccines. The $5,863,720.17 contract has a period of performance from September 16, 2016 to September 15, 2021. Merck, a major pharmaceutical manufacturer, is providing the CDC with multiple vaccine types for both adult and pediatric populations under this IDV. This includes...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) to Merck Sharp & Dohme LLC, doing business as Merck, a major pharmaceutical manufacturer. The contract has a $2,993,341,000 ceiling value and a period of performance from April 1, 2021 through March 31, 2022. The purpose of this IDC is to provide a range of standard pediatric vaccines required to support immunization...
This is a multiple award Indefinite Delivery Contract awarded by the Centers for Disease Control and Prevention (CDC) to Merck Sharp & Dohme LLC, doing business as Merck, for the procurement of 27 pediatric vaccines to support the CDC's Immunization Awardees program and Vaccines for Children program. The contract has an estimated ceiling value of $4,079,096,100 and a period of performance from April 1, 2024 through March 31, 2025. The vaccines will be shipped F.O.B. destination to the 50...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a multiple award indefinite delivery contract to Merck Sharp & Dohme LLC, doing business as Merck, to provide 2019 Vaccines for Children. The contract has a potential value of $2,495,643,500.00 and a period of performance from April 1, 2019 to March 31, 2020. As a major pharmaceutical manufacturer, Merck will deliver a wide range of pediatric and adult vaccines to fulfill the Vaccines for...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Merck Sharp & Dohme LLC, doing business as Merck, a major pharmaceutical manufacturer and supplier to the U.S. federal government. The contract has a total ceiling value of $3,942,689,200 and a period of performance from April 1, 2023 through March 31, 2024. The purpose of this IDC is to establish contracts for the purchase of a minimum of 100 doses up to maximum quantities...
The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) awarded an indefinite-delivery, indefinite-quantity (IDIQ) contract to Merck Sharp & Dohme LLC, doing business as Merck, for the supply of various adult vaccines. The contract has a potential value of $87,753,075 and a period of performance from July 1, 2023 through June 30, 2024. The vaccines will be delivered within 15 business days of order receipt and shipped FOB...
The Centers for Disease Control and Prevention awarded multiple indefinite delivery contracts to Merck Sharp & Dohme LLC for adult vaccines. The contracts have a potential value of $83,485,760 and a period of performance from July 1, 2021 to June 30, 2022. Merck will provide 13 standard adult vaccines including hepatitis A, hepatitis B, pneumococcal polysaccharide, tetanus/diphtheria toxoids, herpes zoster, measles/mumps/rubella, meningococcal conjugate, human papillomavirus, and...
The Centers for Disease Control and Prevention (CDC) has awarded an Indefinite Delivery Contract (IDC) to Merck Sharp & Dohme LLC, doing business as Merck, for the supply of up to 23 standard pediatric vaccines. The $3.301 billion contract will run from April 1, 2022 through March 31, 2023, supporting the CDC's Immunization Awardees and the Vaccines for Children program under Section 317(j) of the Public Health Service Act. The vaccines being procured include a wide range such as DTaP, Hep...